I've just been reading the NHS guidance on treatment for PMS and was interested to see what it says about Gonadotrophin-releasing hormone (GnRH) analogues - which is the same drug given to trans-identifying children as 'puberty blockers':
www.nhs.uk/Conditions/Premenstrual-syndrome/Pages/Treatment.aspx
It warns that they should only be used in severe cases, where all other treatments have failed and for a maximum of 6 months and warns that it "often" causes side effects including osteoporosis (thinning of the bones).
There is plenty of evidence of this as demonstrated by the stories of a number of young people who were given this drug as children:
www.statnews.com/2017/02/02/lupron-puberty-children-health-problems/
So why, given that the NHS accept that this is a known, common side effect, does the page advising parents of trans-identifying children make no mention of this and say that the effects of giving this drug to prepubescent children are 'fully reversible'?
www.nhs.uk/Conditions/Gender-dysphoria/Pages/Treatment.aspx